Huang H, Tao R, Hao S, Yang Y, et al. Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study. J Clin Oncol 2023 Mar 30:JCO2202367. doi: 10.1200/JCO.22.02367.
PMID: 36996373